Skip to main content

Brook Heaton

Assistant Research Professor of Molecular Genetics and Microbiology
Molecular Genetics and Microbiology
GHRB 1021, Box 103020, Durham, NC 27710
GHRB 1021 BX103020, 905 S LaSalle St, Durham, NC 27710

Current Appointments & Affiliations


Assistant Research Professor of Molecular Genetics and Microbiology · 2019 - Present Molecular Genetics and Microbiology, Basic Science Departments
Member of the Duke Human Vaccine Institute · 2024 - Present Duke Human Vaccine Institute, Institutes and Centers

Recent Publications


The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activity.

Journal Article J Virol · February 25, 2025 Coronaviruses (CoVs) encode non-structural proteins (nsp's) 1-16, which assemble to form replication-transcription complexes that function in viral RNA synthesis. All CoVs encode a proofreading 3'-5' exoribonuclease in non-structural protein 14 (nsp14-ExoN ... Full text Link to item Cite

Fluorescent and bioluminescent bovine H5N1 influenza viruses for evaluation of antiviral interventions.

Journal Article J Virol · November 19, 2024 In early 2024, a clade 2.3.4.4b high pathogenic H5N1 avian influenza virus was detected in dairy cows and humans in the United States. Since then, it has spread to herds in at least 13 states and caused symptomatic disease in at least fifteen people. To fa ... Full text Link to item Cite

Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes.

Journal Article J Virol · October 22, 2024 Seasonal influenza vaccines provide mostly strain-specific protection due to the elicitation of antibody responses focused on evolutionarily plastic antigenic sites in the hemagglutinin head domain. To direct the humoral response toward more conserved epit ... Full text Link to item Cite
View All Publications

Recent Grants


CIVICs A Option 22D

ResearchInvestigator · Awarded by National Institutes of Health · 2024 - 2026

SRA - Neutralization capacity of purified anti-SARS-CoV-2 monoclonal antibodies

ResearchPrincipal Investigator · Awarded by Invivyd, Inc. · 2025 - 2026

CIVICS Component A - Option 5

ResearchResearch Associate · Awarded by National Institutes of Health · 2019 - 2025

View All Grants

Education, Training & Certifications


The University of Chicago · 2012 Ph.D.